Download Citation
Article Source:
Efficacy and safety of gemcitabine plus docetaxel in Japanese patients with unresectable or recurrent bone and soft tissue sarcoma: Results from a single-institutional analysis
Takahashi M,
Komine K,
Imai H,
Okada Y,
Saijo K,
et al.
(2017)
Efficacy and safety of gemcitabine plus docetaxel in Japanese patients with unresectable or recurrent bone and soft tissue sarcoma: Results from a single-institutional analysis.
PLOS ONE 12(5): e0176972.
https://doi.org/10.1371/journal.pone.0176972